g epigenetic regulatory mechanisms in human disease · “genetic and epigenetic regulatory...

47
ARMENISE-HARVARD SYMPOSIUM 2007 GENETIC AND EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE 11th Annual Symposium June 8-11, 2007, Hyatt Regency Newport Hotel and Spa, Newport, Rhode Island About the Symposium Although most educated people view DNA as the molecule solely responsible for inheritance, a more complex and nuanced story unfolded during the 11th Annual Symposium of the Giovanni Armenise-Harvard Foundation. Held in Newport, Rhode Island, on June 8-10, this year’s theme was “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. Anyone tall enough to peer through a microscope can see that fat, hemoglobin-rich blood cells don’t look anything like neurons with their long, spidery arms. Yet the same DNA is packed into the nuclei of these wildly different cells. So DNA, scientists now say, is not all there is. Today’s consensus is that structural and functional differences among cell types are determined by “epigenetic” programs that regulate DNA’s activity, some of them marks from environmental assaults, some a form of memory. What makes these proteins and small molecules so important is their capacity to change genetic expression without altering DNA sequence itself. Epigenetic changes turn an embryonic stem cell into a specialized adult cell and transform normal cells into tumors, according to Whitehead Institute investigator Rudolph Jaenisch. In his keynote address, Jaenisch said understanding how to program and reprogram different types of cells is one of the most important topics in biology today, because such skills would hold enormous promise for treating the ills of humankind. Epigenetic “reprogramming” is a key step for creating stem cell therapies for cancer and progressive disorders such as Parkinson’s disease, yet these efforts are ensnared in ethical and political complications. Two days before the symposium began, the House of Representatives voted to expand government-supported stem cell research, a piece of legislation destined for Presidential veto despite protests from patients and families. On the same day, Nature published important stem cell findings from Jaenisch’s lab. Elsewhere, cancer patients were participating in clinical trials testing drugs with epigenetic activity, hoping for cures. These are the real-world complications of the basic science presented by Jaenisch, 18 other speakers and numerous poster presenters at the 2007 symposium. Participants convened at the

Upload: truongnga

Post on 15-Feb-2019

227 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

ARMENISE-HARVARDSYMPOSIUM2007

GENETICANDEPIGENETICREGULATORYMECHANISMS

INHUMANDISEASE11thAnnualSymposium

June8-11,2007,HyattRegencyNewportHotelandSpa,Newport,RhodeIsland

AbouttheSymposium

AlthoughmosteducatedpeopleviewDNAasthemoleculesolelyresponsibleforinheritance,amorecomplexandnuancedstoryunfoldedduringthe11thAnnualSymposiumoftheGiovanniArmenise-HarvardFoundation.HeldinNewport,RhodeIsland,onJune8-10,thisyear’sthemewas“GeneticandEpigeneticRegulatoryMechanismsinHumanDisease”.

Anyonetallenoughtopeerthroughamicroscopecanseethatfat,hemoglobin-richbloodcellsdon’tlookanythinglikeneuronswiththeirlong,spideryarms.YetthesameDNAispackedintothenucleiofthesewildlydifferentcells.SoDNA,scientistsnowsay,isnotallthereis.

Today’sconsensusisthatstructuralandfunctionaldifferencesamongcelltypesaredeterminedby“epigenetic”programsthatregulateDNA’sactivity,someofthemmarksfromenvironmentalassaults,someaformofmemory.WhatmakestheseproteinsandsmallmoleculessoimportantistheircapacitytochangegeneticexpressionwithoutalteringDNAsequenceitself.

Epigeneticchangesturnanembryonicstemcellintoaspecializedadultcellandtransformnormalcellsintotumors,accordingtoWhiteheadInstituteinvestigatorRudolphJaenisch.Inhiskeynoteaddress,Jaenischsaidunderstandinghowtoprogramandreprogramdifferenttypesofcellsisoneofthemostimportanttopicsinbiologytoday,becausesuchskillswouldholdenormouspromisefortreatingtheillsofhumankind.Epigenetic“reprogramming”isakeystepforcreatingstemcelltherapiesforcancerandprogressivedisorderssuchasParkinson’sdisease,yettheseeffortsareensnaredinethicalandpoliticalcomplications.Twodaysbeforethesymposiumbegan,theHouseofRepresentativesvotedtoexpandgovernment-supportedstemcellresearch,apieceoflegislationdestinedforPresidentialvetodespiteprotestsfrompatientsandfamilies.Onthesameday,NaturepublishedimportantstemcellfindingsfromJaenisch’slab.Elsewhere,cancerpatientswereparticipatinginclinicaltrialstestingdrugswithepigeneticactivity,hopingforcures.

Thesearethereal-worldcomplicationsofthebasicsciencepresentedbyJaenisch,18otherspeakersandnumerousposterpresentersatthe2007symposium.Participantsconvenedatthe

Page 2: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

HyattRegencyNewportHotelandSpaonJune8-10,markingthesymposium’sreturntotheUnitedStatesafterfourconsecutivemeetingsinItaly.PowerfultiestoHarvardsciencemadeNewportanappropriatesettingforthisyear’smeeting.ItwasherethatAlexanderAgassiz,curatorofHarvard’sMuseumofComparativeZoology,constructedapioneeringmarinebiologylaboratoryin1875.Forthenext25years,hisresearchteamssetsailfromNewporttoprobethephysical,chemical,biologicalandgeologicalfeaturesofthegreatoceanbasins.

Agassiz’sengineeringtalentshadalreadymadehimwealthyintheminingindustry;inhissecondcareerheusedtheseskillstoinventnewtechnologiesforgatheringspecimensandtakingmeasurementsindeepwater.Longbeforeanyonedreamedofunmannedsubmersiblesorfiberoptics,hemadeobservationsaboutstarfishes,seaurchinsandothermarinecreaturesthatarestillcitedtoday.

Thecontemporaryquesttounderstandhowepigeneticfactorscontrolgeneticinformationisaschallengingasdeep-seaexplorationwasfortheVictorians.Yetprogressisbeingmade.Somepresentersdescribedhowepigeneticfactors,suchaschromatinpackagingandmethylation,establishacell’sidentityyetleaveitsusceptibletochange.Othersfocusedonepigeneticfunctionsasawayofrecordingwhathappenedtoonegenerationandpassingthatmemorytothenext.

Sixtyparticipantsacceptedtheinvitationtothisyear’ssymposium.ScientistsrepresentedHarvardMedicalSchoolanditsaffiliatedinstitutions,MassachusettsInstituteofTechnology,YaleUniversity,nineItalianuniversitiesandresearchinstitutesandonemultinationalpharmaceuticalcompany.FoundationPresidentJosephB.Martin,deanofHMS,presidedandPresidentEmeritusDanielC.Tosteson,formerdeanofthemedicalschool,attendedalongwithmembersoftheFoundation’sBoardofTrustees,ScientificAdvisoryboardandItalianScholarshipAdvisoryCommittee.Attheirannualmeeting,theBoardofTrusteesvotedtocreateanewArmeniseFoundationChairatHMS.CountGiovanniAulettaArmenise,whocouldnotbepresentinNewport,joinedthisdecisionviatelephonefromItaly.TheBoardnamedStephenC.Harrison,directoroftheArmenise-HarvardCenterforStructuralBiology,asthefirstholderofthisendowedchair.Harrison’sappointmentwasannouncedtosymposiumparticipantsbyDeanJosephMartin.

TheprogramfeaturedtalentedyoungscientistswhohavebenefitedfromFoundationprogramsatHMSandinItaly.FourwinnersofHMSJuniorFacultyGrantsparticipatedinthesymposium,includingtwoofthreeresearchershonoredin2007.TheywerejoinedbysevenrecipientsofCareerDevelopmentAwards,whichenableItalianstoreturnhomeandestablishtheirownlaboratoriesaftercompletingpost-doctoraltrainingabroad.TheDulbeccoTelethonInstitutealsomakesresearchgrantsforthispurpose,andtheFoundationinvitedTelethon-supportedepigeneticsresearcherstojointhisyear’ssymposiumandmeetpotentialcollaborators.

AlsoonhandweretwoItaliansciencejournalists,thelatestrecipientsoftheannualScienceWriterFellowshipsthatenableItalianreporterstoresearchstoriesoftheirchoosingatHMSandparticipateinthesymposium.

Page 3: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<palign=""left""><strong>Pluripotency,EpigeneticReprogrammingandEmbryonicStemCells</strong></p>

RudolfJaenisch

WhiteheadInstituteforBiomedicalResearchandDepartmentofBiology,MassachusettsInstituteofTechnology,Cambridge,MA

<ahref=""mailto:[email protected]"">[email protected]</a>

Thirtyyearsago,youngRudolphJaenischbecamefamousbeyondhisyearsbycreatingthefirsttransgeniclaboratoryanimalsinhistory.HeshowedthatwhenMoloneyleukemiaviruswasinjectedintoearlymouseembryos,viralgenesequencesnotonlyintegratedintotheDNAoftheseanimalsbutalsopassedtotheiroffspring.

OnthedaybeforetheArmenise-HarvardSymposiumbegan,Jaenischmadeheadlinesforadifferentreason:hisgroupandtwootherteamsrevealedthattheyhadtransformedadultskincellsintopluripotentembryonicstemcells.Thesecellswereincorporatedintodifferenttissuetypesandcouldbeinheritedbyoffspring.Importantly,thesegroupshadcreatedembryonicstemcellswithoutrunningafoulofcontroversiesaboutusingeggsordestroyingembryos.

Page 4: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<palign=""left"">IntheJaenischlab,thisaccomplishmentbuildsonmorethantwodecadesoftherapeuticcloningresearch.Usingmiceasamodel,theresearcherssubstituteDNAfromafibroblastfortheoriginalDNAinanunfertilizedegg,whichisthengrownintoablastocysttogeneratestemcellsforanimal“patients.”AlthoughJaenischbelievesthisapproach–knownassomaticcellnucleartransfer,orSCNT--couldbesuccessfulinhumanpatients,hesaiditis“notfinanciallyfeasible,itistoodifficulttoobtainenougheggs,andtherearemanyethicalbarriers.”</p>

<palign=""left"">Inthecourseofhisnuclearcloningexperiments,Jaenischwasintriguedbythepossibilityofresettingtheepigenetichallmarksofanadultdonornucleustothoseofanembryoniccell.Toaccomplishthis,Jaenischreckonedhewouldneedtounderstandhowembryonicstem(ES)cellsreplenishthemselveswhilestillbeingabletodifferentiateintonearlyanytypeofadultcell.</p>

<palign=""left"">Fortunately,histeamandothershavelearnedagreatdealaboutthemolecularcircuitryofpluripotencyandself-renewal,makingitpossibletodifferentiatepluripotentcellsintovariousspecificcelltypesandtotakesomaticcellsbackwardintime,restoringelasticitytheypossessedatanearlierdevelopmentalstage.</p>

<palign=""left"">JapaneseresearcherShinyaYamanakaandhiscolleaguesatKyotoUniversitywereengagedinasimilarquest,andinAugust2006theyreportedthatactivatinggenesforfourtranscriptionfactorsinskincellsfromadultmicehadreturnedthosecellstoapluripotentstate.Unfortunately,thesecellswerenotasflexibleasrealembryonicstemcellsandcouldnotbeusedtogeneratelivemice.</p>

<palign=""left"">Jaenisch’slabsetouttorefinetheseexperiments,andafterscreeningvarioustranscriptionfactorsforgenome-wideactivitytheresearchersdecidedtofocusonOct4andNanog.Thesefactorsareactive<em>only</em>infullypluripotentcells,wheretheystimulateanarmadaofgenesthatretainelasticityandrepressgenescontrollingdifferentiation.TheteamdevisedaclevermethodforcollectingcellssuccessfullyreprogrammedbyactiveOct4andNanog,thentestedtheircapacitytobehavelikeembryonicstemcells.</p>

Thereprogrammedcellscontributedtoeverytissuetypeafterbeinginjectedintoearly-stageembryosandtheseembryosdevelopedintolivemice.Whenthesemicewerebred,descendentsofthereprogrammedcellsweredetectedinthenextgeneration.Additionalexperimentswere

Page 5: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

performedaswell,andthealteredcellswereindistinguishablefromembryonicstemcellsonallcounts.

<palign=""left"">Whenitcomestocell-basedtherapyforhumandisease,however,“wearenotthereyet,”Jaenischcautioned.Theretroviralvectorsusedtoreprogramthecellsareoncogenicandcouldnotbeethicallyusedinhumans,scientistsdon’tknowwhetherthetranscriptionfactorsthatreturnmousefibroblaststopluripotencywouldworkforhumans,andbetterwaysareneededtoseparatereprogrammedcellsfromadultcellsthatdidnotsuccumb.</p>

<palign=""left"">Ultimately,findingslikethesecouldpropelcell-basedtreatmentsforhumandiseaseoverscientificandethicalhurdlesassociatedwithusinghumanembryosfortherapeuticpurposes.Fornow,however,thesefindingsare“preliminaryandproofofprinciple,”Jaenischsaid.</p>

&nbsp;

<strong>Presentations</strong>

<strong>SystemsAnalysisofHumanMitochondrialDisorders</strong>

VamsiK.Mootha,MD

Page 6: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

DepartmentofSystemsBiology,HarvardMedicalSchool,

CenterforHumanGeneticResearch,MassachusettsGeneralHospital,andtheBroadInstituteofMITandHarvard

<ahref=""mailto:[email protected]"">[email protected]</a>

AssoonasmitochondrialDNAbecame“thefirsthumangenomeeversequenced,”backin1981,scientistsrecognizedthatitencodedonly13completeproteins.Sincethen,about50humandiseasesandsyndromeshavebeenattributedtomitochondrialabnormalities.Thesediseasesaredifficulttodiagnoseandsofartherearenocurativetherapiesforanyofthem.

What’sfascinating“isthatmostclinicalmitochondrialpatientsdonothavelesionsinthetinymitochondrialgenome–onlyabout15percentdo,”VamsiMoothasaid.“Theresthaveproblemswithnucleargenomeproteinsthatregulatemitochondrialactivity.”Itappearsthatmitochondriadrawnuclearproteinsintotheirorbit,andthenewrecruitscancauseproblems.

<palign=""left"">Mootha’slaboratoryuseshumangenomesequencedata,microarrays,andcomputeralgorithmstosystematicallylinkmitochondriatohumandiseases.Severalyearsago,MoothaandhiscollaboratorsusedthesetoolstoidentifythemutationresponsibleforLeigh

Page 7: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

syndrome,FrenchCanadiantype.ThislethaldiseasewastragicallycommonamongchildreninaremotepopulationinQuebec,affectingoneinevery2,000.Mootha’sworkledtoaprenataltestnowbeingusedbyfamiliesatrisk.</p>

<palign=""left"">TheMoothateamhassincecreatedanewsystem,called“Maestro,”thatishelpingthemconstructacompleteproteinatlas,orproteome,formitochondria.Thissystemintegratesdatafromeightdifferentproteinscreeningmethods,cross-checkingoneagainsttheothers,topinpointproteinsactiveinmitochondria.Sofar,itappearsthatabout1,500proteinsfunctioninthistinybutindustriousorganelle.</p>

<palign=""left"">Theteamisusingthis“partslist”tolookforspecificgenedefectsassociatedwithraremitochondrialdisorders,andthesearchisgoingwell.MoothacollaboratedwithMassimoZeviani’slaboratoryattheNationalNeurologicalInstituteinMilantochangemisconceptionsabouthepaticmitochondrialDNAdepletionsyndrome,adisorderthathadbeenattributedtoperoxisomemalfunction.</p>

<palign=""left"">TherealculpritisadefectinMPV17,whichencodeskeycomponentsofthemitochondrialmembrane.InaposterpresentationattheSymposium,AntonellaSpinazzoladescribedtheimpactofthismutationinfamiliesstudiedinItalyandonaNavahoreservationintheUnitedStates,aswellasinamousemodelofdisease.</p>

<palign=""left"">OngoingworkintheMoothalabisaimedatachievingasystems-levelunderstandingofmitochondriathatwillimprovediagnosisandtreatmentformanyother,morecommonhumandiseases.</p>

<strong>TargetingtheB-cellAntigenReceptorinBLymphomaCells:LessonsfromMouseModels</strong>

<palign=""left"">StefanoCasola</p>

FoundationIFOM,theFIRCInstituteofMolecularOncology,Milano,andtheCBRInstituteofBiomedicalResearch,HarvardMedicalSchool

Page 8: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<ahref=""mailto:[email protected]"">[email protected]</a>

Theincidenceofnon-Hodgkin(NHL)lymphomashasdoubledoverthepasttwodecades,advancingittofifthplaceonthelistofcommoncancersamongmenandwomen.IntheUnitedStates,morethan63,000newNHLcasesarediagnosedeachyearandnearly20,000peopledie.Thisincreaseisunlikelytoleveloffbecausetheselymphomasareassociatedwithrisingratesofinfectiousdiseases,autoimmunedisorders,andtoxicenvironmentalexposures.

CliniciansneednewtherapiesforNHLpatients,80to90percentofwhomhaveB-celltumorsthatoriginateinlymphoidtissue.StefanoCasolausesmousemodelstopeerinsidetinyfactorieswheresomeBcellsareprogrammedtostandwatchagainstinvaders.Whilenormalsentriesdieattheendoftheirshift,otherslivetoolongandturntraitorous.AsurfacecomplexcalledtheBcellantigenreceptor(BCR)isimportantfortheirdifferentiation,proliferationandlifespan.MatureBcellsundergoapoptosiswhenBCRislostafterseveralweeks.

<palign=""left"">Incontrast,functionalBCRexpressionpersistsinmosttypesofNHLcells,includingBurkitt’s,follicularlymphomaanddiffuselargeB-celllymphoma.Casola’steamsetouttounderstandtheroleoftheBCRinthesecancercells,andtoseewhatwouldhappeniftheymanipulatedthiscomplexincellsfrommicewiththeequivalentofBurkitt’slymphoma.</p>

Ahumanc-MYConcogenewasusedtoinducetumorsthatlooklikehumanBurkitt’slymphomaunderthemicroscopeandhavethesamecellsurfacemarkers.Inaseriesof<em>invivo</em>and<em>invitro</em>experiments,theresearchersselectivelyblockedtheactivityofBCRandothergenesthoughttobeinvolvedinBcellsurvival,proliferationanddifferentiation.

Page 9: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

WhentheresearchersdisabledBCR,B-lymphomacellsisolatedfromindependentprimarytumorsrapidlydied,both<em>invitro</em>and<em>invivo</em>.ComparedwithBCR+cells,theBCR-oneswerethreetimesmorelikelytoundergoapoptosis.Forreasonsthatarepoorlyunderstood,thecellssuddenlydeprivedofBCRdiedonlywhenBCR+cellswerepresent.It’spossiblethathavingBCRisanadvantageonlywhenBCR-cellsarealsopresentandcompetingfornutrients,asituationCasolacharacterizedas“restrainedgrowth.”HeseespreliminaryevidencethatBCR+cellsmaybebetterabletotakeupglucoseinthissetting,enablingthemtooutcompeteBCR-cells.

CasolaandhisteamarenowlookingforhighlyconservedstepsintheBCRsignalingcascaderegulatedbyepigeneticfactorssuchashistonemodifiers.TheymaybeabletohastenthedeathofmalignantBcellsiftheycanidentifysuchinterimsteps.

<strong></strong>

<strong>TumorSuppressorActivityoftheHistoneAcetyl-TransferaseTip60</strong>

BrunoAmati

Page 10: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

DepartmentofExperimentalOncology,EuropeanInstituteofOncology(IEO),

IFOM-IEOCampus,Milano

<ahref=""mailto:[email protected]"">[email protected]</a>

Drunkenteenagerschallengeoneanothertojumpfromadangerouslyhighrailroadtrestle.Whenonemakesamovetowardtheedge,he’sunlikelytoleapifheisrestrainedbyafriendoneachside.Butifthereisonlyonefrienddragginghimback,thedangerincreasesthathe’llbreakfreeandtaketheplunge.

Apparentlythesameistrueforcancercells,whicharetornbetweenthedrivetoproliferatewildlyandthemoresoberimpulsetostopdividingandundergonormalapoptosis.Havingtwocopiesoftumorsuppressinggenesonhandreducestheriskofmalignanttransformation;butifonecopyislost–sothatthetumorcellsbecome“haplo-insufficient”–anythingcanhappen.

BrunoAmati’slabinvestigatesepigeneticregulationofhumordevelopment,andhissymposiumpresentationfocusedonTip60,anacetyl-transferasethatmodifieschromatinstructureandinfluencestranscriptionfactorsthateitherpromoteorsuppresstumorigenesis.Tip60hasbeen

Page 11: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

characterizedasahaplo-insufficienttumorsuppressorinhumanbreastcancer,andAmatiusesmousemodelstoprobeitsactivitiesindetail.

Inthesemodels,theMyconcogenepromotesBcelllymphomawhileparadoxicallyactivatingDNA-DamageResponse(DDR)signaling,atypeoftumorsuppression.Pre-tumoralB-cellsofyoungEm-mycmiceshowedasustainedDDRasjudgedbyphosphorylationofATM,H2AX,Chk1,Bidandp53(Ser15).

WhenEm-myctransgenicmicewerecrossedwithheterozygousTip60knockoutanimals,DDRwasseverelyimpairedandtumorsgrewfaster,eventhoughtherewasnosignificantchangeinpre-tumoralB-cellexpansion,S-phaseorapoptosis.Theresearchersweresurprisedtoseethatthewild-typeTip60allelewasneverlostinlymphomas,butwasduplicatedinstead.TheyconcludedthatTip60actsasahaplo-insufficienttumorsuppressorduringearlytumordevelopment,butnotwhencancerismoreadvanced.

MycisastronginduceroftheARF-p53tumorsuppressorpathway.LymphomasarisinginEm-mycp53+/-micelosetheremainingp53allele,exceptwhenthislossofheterozygosity(LOH)isblockedbysecondarymutationsthatimpingeonp53activityand/orapoptosis.InlymphomasarisinginEm-mycp53+/-Tip60+/-mice,however,secondarymutationsdidnotpreventp53LOH.AsimilarobservationwasmadeforARFLOHinEm-mycARF+/-Tip60+/-mice.SelectivepressuretolosetheARF-p53pathwayinthesemiceimpliesthatTip60haplo-insufficiencydoesnotbypassARF-p53function,eventhoughp53phosphorylationisimpaired,Amatisaid.RedundantmechanismsforDDRmustbesuppressingtumorgrowthbyothermeans.

Page 12: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Finally,thehaplo-insufficienttumorsuppressoractivityofTip60appearstokickinonlywhenoncogenesareactiveinincipienttumorcells.Liketheboywhopullsafriendbackfromtheedge,restraintisneededonlywhendangerthreatens.

&nbsp;

<strong>SonicHedgehog—ProteoglycanInteractionsinDevelopmentandDisease</strong>

RosalindSegal

DepartmentofNeurobiology,HarvardMedicalSchoolandDepartmentofPediatricOncology,Dana-FarberCancerInstitute

<ahref=""mailto:[email protected]"">[email protected]</a>

Page 13: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Sonichedgehogisoneofthebestknownmorphogensinbiology,andarguablythemostcolorfullynamedofthesignalingproteinsthattouchlargegroupsofembryoniccellsandguidethemtoformspinalcords,wingsorfingers.Sonichedgehog(Shh)promotessynchronizedgrowthandspecifiescellfateaspatternsdevelopincomplextissues.

Shhisanexceptionallyversatileproteinthatactsonmanyeukaryoticintracellularpathways.RosalindSegalexaminesShh’sinteractionswithproteoglycansfoundoutsidethecells,intheextracellularmatrix,andaskshowthesemightbeimportantforoncogenesis.ThisisaclinicallyimportantquestionbecauseShhoveractivityhasbeendescribedinsometumorsofthebrain,skin,breastandpancreas.

Inanimalmodels,asinhumancells,theCardin-WeintraubmotifinShhproteinbindstightlywithheparin-sulfateproteoglycans.WhenSegal’steamintroducedmutationsthatdisruptedthisbinding,themicehadfeaturesthatwerenormallypatternedbutabnormallysmall.Observationsinmiceand<em>Drosophila</em>indicatethatsuchdisruptionsinterferewithShh’snormalexpansionofstemcellpoolswithoutaffectingmorphogenesis.

Morerecently,theSegallabhasbeenexploringhowShh-proteoglycansinteractionsaffectwhathappensduringmitosis.Likemanyotherresearchers,she’sbecomefascinatedbyhowsignalsfromoutsidethecell,suchasproteoglycans,integratewithintrinsiccellfateprogramstoregulatecelldivision.Duringnormalstemcellmitosis,onedaughterisliketheoriginal–replenishingthestemcellpool–whiletheotherpreparestodifferentiate.This“asymmetric”divisionmaintainsnormalgrowthanddevelopment.

Page 14: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Inneuralstemcells,however,SegalandhercolleaguesintroducedmutationsthatdisturbedtypicalShh-proteoglycaninteractionsand–amongothereffects–induced<em>Gli3,Bmi1</em>and<em>cyclinD1/2.</em>Insteadofundergoingnormal,asymmetricdivision,thesecellsdividedmuchfasterthanusual.Heparin-sulfateproteoglycanslocalizesShhtomitogenicniches,andundercertainconditionsappearstoholdthepedaltothemetal,speedingupcelldivisiontoamalignantdegree.

Segalemphasizedthatthisisonlyapreviewofwhat’stocome.“Therearemoretypesofproteoglycansinamammalthantherearestarsinthesky,”shesaid,andshehopesthatgeneticapproachesto“glycomics”willbeabletofingermoreofthebadactors.Andthis,inturn,raisesthepossibilityofshrinkingtumors–withoutharmingnormaldevelopment–byblockingspecifictypesofproteoglycansactivity.

<strong>CellularandOrganismToxicityinaDrosophilaModelforthePolyglutamineDiseaseDRPLA</strong>

Manolis<strong></strong>Fanto

DulbeccoTelethonInstitute,DIBIT-SanRaffaeleScientificInstitute,Milano

Page 15: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<ahref=""mailto:[email protected]"">[email protected]</a>

AlthoughHuntington’sistheonlypolyglutamine(polyQ)diseasemostpeopleknowabout,itisonlyoneofaboutadozenprogressiveneurologicaldisordersinthisgroup.Whattheyshareisthegeneticequivalentofastutter–relentlessrepetitionofCAG,threenucleotidesthatencodetheaminoacidglutamine.Thishappensinaso-calledpolyglutaminetract,apartofthegenewheremultiplecopiesarenormal.Whenstutteringgeneratesexcesscopies,theresultingproteinnolongerplayswellwithothers,clogsnervecellswithdepositsthatstubbornlyresistdegradation,andultimatelykillsthecells.

Becauseeachdiseaseinthisgroupdamagesaspecificproteinanddestroyscellsinaspecificbrainregion,theirsymptomsaredifferent.Nevertheless,allthePolyQdiseasesworsenwithtimeandshareagrimprognosis.

Muchofwhat’sknownaboutthesedisorderscomesfromexperimentsusingthefruitfly<em>Drosophila</em><em>melanogaster</em>,andManolisFantousesnovelfliestoinvestigatedentatorubropallidoluysianatrophy(DRPLA),adisordercausedbyPolyQexpansioninthehumangeneforAtrophin-1.Healthypeoplehavesixto35copiesoftheCAGrepeatinthisgene;DRPLApatientshave49-88.

AlthoughsomeflymodelsforDRPLAusehumangenesorsyntheticconstructs,FantoandhiscolleagueshavegeneratedamodelbyexpandingendogenouspolyQin<em>atro.</em>

Page 16: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Theycombinegainoffunctionandclassiclossoffunctionanalysistounravelthecellularandorganismconsequencesofmutationsin<em>atro</em>anditspartner<em>fat.</em>Histeamanalyzescelldegenerationinneuronalphotoreceptorsanduseslifespanasameasureofoveralltoxicity.

WhenresearchersinducedtheflyequivalentofDRPLAbyexpandingapolyQtractinatrophin,theflyretinadevelopedabnormalvacuolesandtheanimalsdiedshortoftheirnormallifespan.NewfindingsindicatethatthelargerthepolyQexpansiontheworsetheretinaldamage,whichtheyattributetodisruptionofautophagyratherthaninductionofapoptosis,Fantoreported.Autophagynormallyprotectscellsbyclearingawayspentorganelles.

AbnormalfoldingmakesexcessPolyQproteinsclumsywhentheyinteractwithintracellularpartners.Atrophinandthegiganticcadherinandtumoursuppressor<em>fat</em>arepartofaneuroprotectivepathway,andFanto’sexperimentshaveshownthatcertainmutationsineitheronecancauseneurodegeneration,killingretinalneuronsandabbreviatinglifespan.Themostsurprisingfindingwasthattheorganismdiesfasterthanacelldegenerates,andthatthiseffectonviabilityisexertedbyglialcellsaswellasbyneurons,Fantosaid.

Althoughthesestudiesarefarfromcomplete,theyhintthatthecomplexityandvariationinpolyQdiseasesmayarisenotonlyfromthedeathofcellsinaspecificbrainarea,buttomorewidespreadtoxicityaffectingthewholenervoussystem.Thenextstepsaretodiscoverthemechanismsinvolved.

Page 17: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

&nbsp;

<strong>TargetingActiveGenesforHistoneModificationin<em>Drosophila</em></strong>

MitziI.Kuroda

HowardHughesMedicalInstitute,Harvard-PartnersCenterforGeneticsandGenomics,Brigham&amp;Women’sHospitalandDepartmentofGenetics,HarvardMedicalSchool

<ahref=""mailto:[email protected]"">[email protected]</a>

MitziKuroda’slaboratoryfocusesonafundamentalquestioninbiology:howdoorganismsbalancegeneexpressioninmalesandfemales,whenmaleshaveonlyoneXchromosomeandfemaleshavetwo?

Page 18: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Theanswerliesin“dosagecompensation,”shesaid,adjustmentstochromatinstructurethatoperatedifferentlyindifferentorganisms.Inmammals,epigeneticmodificationsofhistoneinactivategenesononeoftheX’searlyinfemaledevelopment;infruitflies,modificationsincreaseexpressionofgenesonthesingleXsothattheymatchtheoutputofbothfemaleXchromosomesinmaleembryos.

In<em>Drosophila,</em>dosagecompensationiscarriedoutbyalargeribonucleoproteincomplexcontainingMSL(male-specificlethal)proteinsandnoncoding<em>roX</em>(RNAonX)RNAs.Thisribbon-likecomplexattachesitselfonlytothemaleXchromosome,whereitaltershistoneH4acetylationandencouragestranscriptionofX-linkedgenes.

The<em>RoX</em>RNAsdifferdramaticallyinsizeandsequence,yettheyarefunctionallyredundantandnecessaryforassemblingtheMSLcomplex.Oncethecomplextakesshape,itconsistsoffiveMSLproteins:ifoneismissingorinactivatedthemaleembryodies.

ResearchershavestruggledtounderstandhowtheMSLcomplextargetsspecificsitesontheXchromosomewherebindingwillincreasegeneexpression.Kuroda’steamuseda“ChIP-chip”strategy,whichcombinesmicroarraytechnologywithchromatinimmunoprecipitation,togeneratehigh-resolutionimagesofMSLbindingandhistonemodification.Theyobservedwild-typeMSLbindingto800sitesonXchromosome–97%ofthemovergenesandmostnearthe3’end,Kurodasaid.MSLisattachingitselftoH3K36me3,atargetingmarktypicallyconcentratednearthe3’endofgenesandabundantontheXchromosome.

Page 19: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Inanotherseriesofexperiments,KurodasetouttounderstandMSL’sstrongpreferenceforbindingtheXchromosomeandshunningautosomes.Whentheinvestigatorsinserteda<em>roX1</em>ora<em>roX2</em>genomictransgeneinanautosome,MSLwaseagertobindthesefamiliarpartners.TheyweresurprisedtofindthatonautosomestheMSLcomplexcouldalsospreadlongdistancesfromtheoriginal<em>roX</em>insertionsite,attachingitselftoactivegenesmarkedbyH3K36me3witha3’bias.

Together,thesedatasupportamodelinwhichMSLcomplexisinitiallyrestrictedtoachromatindomainbyhighaffinitysitessuchas<em>roX</em>genes,butthenscansthechromosomeforgeneralmarkssuchasH3K36me3.MSLcomplexandactivechromatinmarkssuchasH3K36me3areconservedinmammals,Kurodanoted,improvingtheoddsthatthisrecruitmentmechanismwillproveimportantformorethan<em>Drosophila.</em>

<strong></strong>

<strong>HistoneDemethylasesandHumanDiseases</strong>

YangShi

Page 20: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

DepartmentofPathology,HarvardMedicalSchool

<ahref=""mailto:[email protected]"">[email protected]</a>

“Understandingbiologicalimportanceisthenextstep,”YangShisaidattheendofhis2006symposiumpresentation.Hislabpioneeredtheideathathistonemethylationisdynamicwhentheyclonedthefirstdemethylasein2004.Initiallytheycouldremoveonlyoneortwomethylgroupsfromalysineresidue,anditseemedthattrimethylgroupsmightbepermanentlyattached.Thiswasdiscouraging,becausethistypeofhistonemodificationappearstolockgenesassociatedwithvariouscancersandneurologicabnormalitiesinthe“on”position.

Then,shortlybeforethe10<sup>th</sup>Armenise-HarvardSymposiumlastyear,Shi’steamidentifiedanenzymefamilythatknockedtrimethylsofftheirhistoneperchesinculturedhumancellsandlivenematodes.Inthenematodes,addingandremovingmethylgroupsdeterminedwhethercellslivedordied.

Page 21: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Ahallmarkoftheseproteinsisthecruciform“Jumanji”domain,whichisfoundinabout30humanproteinfamilies.Theresearchersscreenedthesefordemethylatingenzymesanddiscoveredfourproteinsthatsnippedgroupsortwoorthreemethylsoffmedicallyinterestingsites.

OneoftheseisencodedbySMCX(orJARID1C),andcertainpointmutationsinthisgeneareassociatedwithX-linkedmentalretardation(XLMR).AlthoughpreviousresearchforgedlinksbetweenthesemutationsandXLMR,exactlyhowthesemutationsdamagedbraindevelopmentwasnotknown.

Shinowhasanidea.SMCXlostdemethylationcapacitywhenpointmutationsfoundinXLMRwereintroducedintoratcerebellargranuleneurons.Postsynapticneuronsnolongerdevelopednormaldendriticspines,anabnormalitypreviouslydescribedinthebrainsofmentallyretardedhumans.

SeparateexperimentsinzebrafishalsoraisethepossibilitythatincreasedneuronalcelldeathmaybepartlytoblameforXLMR.ResearchersfoundthatinzebrafishthehomologofSMCX,whichactsexclusivelyinthebrainduringdevelopment,isessentialfornormalneuronsurvival.

Althoughthere’sdefinitelymoretolearn,Shinotesthatstudieslikethesereinforceconnectionsbetweenbasicchromatinbiologyandhumandisease.

Page 22: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<strong></strong>

<strong>FunctionalInteractionbetweentheNucleosomeRemodelingFactorISWIandCovalentModifiersofChromatin</strong>

DavideF.V.Corona

IstitutoTelethonDulbeccoc/oDipartimentodiScienzeBiochimiche-Universita'degliStudidiPalermo

<ahref=""mailto:[email protected]"">[email protected]</a>

OnTVmakeovershows,swarmsofcarpenters,electriciansandpainterstransformcrampedtracthousesintoshowplaces,shovingpastoneanothertoknockoutwallsandimprovelighting.

Page 23: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Thenucleusofaeukaryoticcellisnotsodifferent.Busycrewsofepigeneticfactorsmodifyhistonesandremodelchromatin,pushingandpullingnucleosomessothatDNAisaccessible,inacontrolledmanner,fortranscription,repair,recombination,andotheressentialfunctions.

“Alltheseactivitiesintegrateinthenucleusandtheyworkatthesametime,”DavideCoronasaidatthesymposium,“butit’snotclearhowtheiractivitiesarecoordinatedtoregulatechromaticstructure,geneexpressionandothernuclearfunctions.”HislabusesgeneticandbiochemicaltoolstosearchforchromatinmodifyingfactorsthatactinconcertwithISWI,ahighlyconserved,ATP-dependentnucleosomeremodelingfactor.

In<em>Drosophilamelanogaster</em>,ISWIregulatesexpressionofabout5percentofthegenomeandisinvolvedinDNAreplication,RNAtranscriptionandchromosomeorganization,Coronasaid.Itsactivitycanbemodulatedbysite-specificacetylationofhistones,andCorona’steamusedflieswithaninheritedeyedefecttoscreenhundredsofmutantgenesthatmightbeconspiringwithISWItounderminenormalchromatincondensation.

Thescreenidentifiedtwomutantgenesofinterest:SIN3AandPARP.Botharehighlyconservedenzymesinvolvedinchromatinmodificationanddynamics.

SIN3Aanditspartner,RPD3,formahistonedeacetylasecomplexinvolvedintranscriptionalrepression.ImmunostainingassaysshowthatISWIandthiscomplexnormallysticktogetheronpolytenechromosomes,butsplitapartonISWImutantchromosomes.Aseriesofexperiments

Page 24: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

confirmedinteractionsbetweenISWIandtheSIN3A-RPD3complexandrevealedwhatCoronacalled“afunctionalantagonismbetweenISWIandtheacetylationofhistoneH4onlysine16.”TheresearchershypothesizethatISWIrecruitstheSIN3A-RPD3complextoproductivelyremodelnucleosomes.

Thesecondinterestingmutationwasinthegenecodingforthepoly-ADP-ribosepolymerase,orPARP,achromatinenzymethatCoronasaidisimportantduringDNAdamageresponseandapoptosis.HeatshockproteinsrecruitPARP,whichloosenschromatinbyaddingpoly-ADP-ribose(PAR)andthuspromotestranscription(whichISWItendstorepress).ISWIispoly-ADP-ribosilated<em>invitro</em>and<em>invivo,</em>whichtheinvestigatorsweresurprisedtofindinhibitsitsATPaseactivitybymakingitlesslikelytosticktothenucleosome.ISWIandPARarelocalizedindifferentchromatindomainsonwildtypepolytenechromosome,butwhenISWIismutatedPARspreadsonthesechromosomes.Chromatin-boundISWIcanbejoltedoffpolytenechromosomesby<em>invivo</em>inductionofchromatinpolyADP-ribosylation,Coronareported.Thisindicatesthatpoly-ADP-ribosylationofISWIinhibitsitsATPaseactivity,causingISWItoloseitsgriponchromatin.

Thesedatashowdifferentepigeneticfactorsworkingtogetherasanetwork,withISWIandcovalentmodifiersofchromatinregulatingchromatinaccessibilityandothernuclearfunctions.Coronathankedthesymposiumorganizersforthe2004Armenise-HarvardFoundationCareerDevelopmentAward,whichmadepossiblethesefindingsandwhathecalled“mynewlifeinPalermo.”

&nbsp;

Page 25: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<strong>PossibleRolesinSilencingforpiRNAs</strong>

BobKingston

MassachusettsGeneralHospital,Boston

<ahref=""mailto:[email protected]"">[email protected]</a>

Althoughmanygenesoscillatebetweentalkingandlistening,somegenesessentialformaintainingparticulartissuetypesmustspendthelifeoftheorganismturnedoninonecelltypeandoffinanother.BobKingston’slabisinterestedinepigeneticregulatorycomplexesthatareasdecisiveasTonySoprano:whentheysilenceagene,itstaysthatway.Thissilenceissoprofoundthatitisheritable,enshrinedinchromatinandpassedfromonegenerationtothenext.

In2006,theKingstonlabandthreeothergroupssimultaneouslydescribedanewclassofsmallregulatoryRNAsthatcanrendergenesmute.ThesehavebeendubbedPiwi-interactingRNA,orpiRNA,becausetheyglomontomembersofthePiwifamilyofproteins.Theseso-calledArgonaute

Page 26: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

proteinsinteractwithpolycombproteins,whichsincethe1940shavebeenknownasheritablerepressorsof<em>Drosophila</em>genes.

OtherlaboratoriesworkingonpiRNAsbeganwiththeprotein-RNAcomplex,thenfiguredouthowtoremovetheRNAcomponentforanalysis.KnowingthatthesespecializedRNAsoccurinegg-andsperm-producingcellsinfruitflies,membersoftheKingstonlabtookadifferentapproach.

PostdoctoralfellowNelsonLaustartedwithrattestesandsetouttoextractRNAsthatmightfunctionastranscriptionalgenesilencers.HepulledoutacomplexcontainingsmallRNAsandRiwi,theratversionofhumanPiwi.TheresearchersdubbedthispiRC.ThesmallRNAsinpiRCarraythemselvesonchromosomesinapatterntypicalforregulatoryenzymes,Kingstonnoted.Approximately94percentofpiRNAsmapto100small(&lt;100kb)genomicloci;atthesesitestheyadhereeithertoWatsonorCrickstrands,oriftheybindbothstrandstheydonotoverlap.Theselocations,Kingstonsaid,appeartobeconservedacrossspecies.

PreparationsofpiRCalsohookupwithrRecQ1,theratequivalentofahelicasethathelpssilencegenesin<em>Neurospora</em>.RecombinantRecQ1andPiwifamilyproteinsappeartointeractdirectly,andinfliesPiwihasbeengeneticallylinkedtotranscriptionalgenesilencing.ExperimentsshowthatthepurifiedcomplexhaspiRNA-directedsliceractivity,whichaddsweighttotheideathatpiRCisaheritablesilencerofmammaliangenes.Kingstonsaidmoreevidenceisneededtoconfirmthis.

&nbsp;

Page 27: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<strong>TheRoleofChromosome3DOrganizationinPolycomb-DependentEpigeneticRegulation</strong>

ValerioOrlando

DulbeccoTelethonInstituteatIGBCNR,NaplesItaly

<ahref=""mailto:[email protected]"">[email protected]</a>

Profoundshiftsingeneexpressionenablecellstodifferentiateorchangemetabolicstate.MuchofthedramainvolvescovalentmodificationsofDNAandchromatinandthree-dimensionalreorganizationofchromosomesandgenesinthenucleus.Together,theseepigeneticfactorscollaboratetoensurethequality,stability,andheritabilityofcell-specifictranscriptionprograms.

Page 28: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

ValerioOrlandowantstounraveltheepigenomicmechanismsthatcontrolcellidentityandcellfateplasticity.Inparticular,hislabstudiesPolycombgroupproteins(PcG),whichplayafundamentalroleindevelopment,stemcellrenewalandtumorprogressionbyshapingchromatinstructure.

In<em>Drosophila</em>,PcGsjoinwiththeirtargetsequences,PolycombResponseElements(PREs),toensureepigeneticheritabilityoftranscriptionprogramsandgenesilencing.Buthow?OnetheoryisthatPREsarecarpenters,buildingstructuresthatsequestercertaingenesandmaketheminaccessiblefortranscription.Likehouses,thesestructuresmaymaintainthestatusquobybeingpassedfromparenttooffspring.

Inaseriesof<em>invivo</em>experimentswith<em>Drosophila,</em>Orlando’steamexploredthedynamic,3-Dstructureofthehomeoticlocusbithoraxcomplex(BX-C).TheyusedChromosomeConformationCapture(3C)toidentifywherePcGbindstoBX-Cduringearlyembryogenesis,thencombinedthisinformationwithdatafromfluorescent<em>insitu</em>hybridization(FISH)andFISH-Immunostaining(FISH-I)analysis.

Theylearnedthatwhenhomeoticgenesarerepressed,PcGproteins,PREsandcorepromotershadinteractedatadistancetobuildtopologicallycomplexstructures.Incontrast,whenthehomeoticgenesareprogrammedtobeactive,PcG-controlledepigeneticDNAelementsdidnotinteract.Finally,Orlandoreportedthatmajorchangesinhigherorderstructuresareessentialtomaintainandstabilizealternativetranscriptionstates,whilehistonemodificationandreducedlevelsofPcGproteinsdefineanepigeneticswitchthatisonlypartiallyheritable.

Page 29: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

FutureexperimentswillsearchforlargeandsmallRNAsinvolvedinhigherorderstructureswithinthenucleus,Orlandosaid,followingcluesthatimplicatetheDicerribonucleaseinchangesto3-Dchromatinstructures.

&nbsp;

<strong>AChromosome-AssociatedSmallRNAAmplificationLoopRequiredforHeterochromatinFormation</strong>

DaneshMoazed

DepartmentofCellBiology,HarvardMedicalSchool

<ahref=""mailto:[email protected]"">[email protected]</a>

Page 30: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Heterochromatinwasfirstdescribedin1928,whenbiologistsrealizedthatcertaintightlycompactedregionsofchromatinstaineddifferentlyfromtherest.Andonlyafewyearslater,<em>Drosophila</em>researchersrecognizedthatgenesaresilencedintheseregions,whichareassociatedwithcentromeres,telomeres,repetitiveDNAelementsandcelldifferentiationgenes,DaneshMoazedsaidinhisopeningremarks.Oneofthemostfascinatingpropertiesofthesedomainsisthattheyareepigeneticallyinheritedeventhroughmanycelldivisions.

Moazedhasbeeninterestedinheterochromatinassemblyandepigeneticinheritanceformorethanadecade,andinitiallyheusedbuddingyeastasamodelsystem.Morerecentlyhislabbeganexperimentingwith<em>S.pombe,</em>orfissionyeast,becauseitsgenesilencingmechanismsmorecloselyresemblethoseofhigheranimals.

Threeyearsago,MoazedandhiscolleaguesdiscoveredsurprisingconnectionsbetweenRNAinterference,orRNAi,andtheassemblyofheterochromatinatfissionyeastcentromeres–aprocessalreadyknowntoinvolvehistonebindingproteinsandmethylationenzymes.TheyhavesinceidentifiedseveralmultiproteincomplexesthatphysicallylinktheRNAipathwaytoheterochromatinassembly,andhaveanalyzedtheiractivities<em>invitro</em>and<em>invivo</em>.

AstheMoazedlabfitspiecesintothiselaboratepuzzle,itappearsthatapositivefeedbackloopdeservescreditforkeepingheterochromatinstrongduringcelldivision.AcomplexdubbedRITSattachessmallRNAtagstospecificchromosomeregionsthatshouldbebundledintoheterochromatin.Anothercomplex,RDRC,workswithRITSandtheDicerribonucleasetogenerateasupplyofsmallinterferingRNA(siRNA).ThesesiRNAs,togetherwithhistoneH3lysine9(H3K9)methylation,createsapositivefeedbackloopthatgeneratesmoresiRNAandmaintainsH3K9methylation.Thesilencingmechanisminvolvesco-transcriptionaldegradationofRNAsthataretranscribedinheterochromaticdomainsbyRNAi-dependentand-independentpathways,aprocessthatMoazedcallsCTGS,orCo-TranscriptionalGeneSilencing.

Page 31: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

ThediscoveryofadirectphysicalconnectionbetweenRNAiandheterochromatinraisesthepossibilityofdevelopingdrugsthatsilencegenesbeforetheyspeak,ratherthantryingtocounteractwhatthey’vealreadysaid.

&nbsp;

<strong>HomologuePairing:RegulatingGenesandDrivingEvolution</strong>

TingWu

DivisionsofGeneticsandMolecularMedicine,HarvardMedicalSchool,

<ahref=""mailto:[email protected]"">[email protected]</a>

Page 32: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

TingWuremembersatriptoSeattle,justafewyearsago,whereshefirstbecameinterestedinultraconservedelements,orUCEs.TheseDNAsequences,atleast200basepairslong,arevirtually100%identicalindistantlyrelatedorganisms.ThisstruckachordwithWu,whoselabhaslongbeeninterestedinhomologyandhomologouspairing.

“Homology–orthenumbertwo–playsahugeroleinthelivesofcells,”Wusaid.ShewonderediftheseUCEs,whichareenrichedinpartsofthegenomebelievedimportantforgeneregulationandexpression,mightbeinvolvedinpairing.Ifso,theymightalsohavesomethingtodowithcopynumbervariations,situationswhereDNAsegmentsdonotmarchdowntheaisleinneatpairs.Herlabwasalreadyinterestedinoddnumbersandthedynamiccapacityofthegenometoaccommodatemanydeletionsandduplicationsfromoneindividualtothenext.

Wususpectedtheremightbeaconnectionbetweenthesetwopuzzles,andthereportsheheardin2004providedcluesaboutwhatthiscouldbe.ResearchersfromtheUniversityofCalifornia-SantaCruzhadidentified481uniqueUCEsconservedamonghumans,rats,andmice.TheseUCEsoccureverywhere<em>except</em>chromosome21andtheYchromosome.

“What’sintriguingabout21andYistheyarethetwochromosomesmostlikelytobefoundinhumansinnumbersotherthantwo,”Wunoted.“Trisomy21(Downsyndrome)isthemostviablehumananeuploidandofcoursethereisasingleYinmales.”

Page 33: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

“WethinkthatpossiblytheseUCEsarelikelytobecopy-counters,andtheirroleistomakesurethateachsegmentofthegenomeoccursexactlytwice,”Wusaid.SheandhercolleaguespredictedthatDNAsegmentspresentincopynumbersotherthantwowouldbedepletedofUCEs.

ComputationalgeneticistAdnanDertihelpedtestthismodelbydeterminingwhetherthreesetsofUCEs,totaling896elements,aredepletedamongtwosetsofhumansegmentalduplications(SDs)andsevensetsofCNVs.TheyfoundastrikingshortageofUCEsinthetwosetsofSDs(P&lt;10<sup>-8</sup>)andsixofthesevensetsofCNVs(P&lt;10<sup>-4</sup>).Theresultsareconsistentwith“astringentwatchingofcopynumbers,”Wusaid.

FutureexperimentswilllookforspecificmotifswithinUCEsandexplorewhethertheirduplicationordeletionisassociatedwithlossoffitnessordeath.

&nbsp;

<strong>TheChicken-and-EggRelationshipbetweenTranscriptionandChromatinandImplicationsforEpigeneticInheritance</strong>

Page 34: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

KevinStruhl

DepartmentofBiologicalChemistryandMolecularPharmacology,HarvardMedicalSchool

<ahref=""mailto:[email protected]"">[email protected]</a>

ExperimentswithyeasthaveenabledKevinStruhlandhiscolleaguestogainsurprisinginsightsintotherelationshipbetweenthe“beadsonastring”structureforDNAstorageandtheapparatusthattranscribesgenes.Theyhavelearnedthatsometranscriptionmechanismsdodoubleduty:notonlylooseningheterochromatinintoreadableeuchromatinbutalsorepackingitintheirwake.

Inlate2005,StruhlandhiscolleaguesmadewavesbydemonstratingthatRNApolymeraseII(PolII)doestwoseeminglyoppositethingsatonce.AsitmovesalongtheDNAtemplateitnotonlyexposesandreadsgenetictext,butalsoknocksoffacetylgroupsandcoversupwhatitjustread.DoingthiskeepsPolIIfrommistakenlybeginningatranscriptionpartwayalongthecodingregion.

Atthesymposium,Struhldescribedhowtheepigeneticreprogrammingofyeastillustratesthechicken-and-eggrelationshipbetweentranscriptionandchromatinstructure.ThesilencingproteinSir3isanestablishedtoolforblockingDNAtranscription,anditinducesheterochromatin

Page 35: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

formationbycausingrapidlossofhistoneacetylation.Removalofeuchromatichistonemethylationwasmoregradual,andoverseveralcellgenerationstheresearchersobservedstructuresthatwereneithereuchromaticorheterochromatic.

Unexpectedly,Sir3bindingandthedegreeoftranscriptionalrepressionincreasedgraduallyforthreetofivecellgenerations,eventhoughtheintracellularlevelofSir3remainedconstant,Struhlreported.StrainslackingSas2histoneacetylaseorthehistonemethylasesthatmodifylysines4(Set1)or79(Dot1)ofH3displayacceleratedSir3accumulationat<em>HMR</em>oritsspreadingawayfromthetelomere,suggestingthatthesehistonemodificationsexertdistinctinhibitoryeffectsonheterochromatinformation.

MethylationofH3K4appearstorepresentwhatStruhlcalledaformofmemory,amarkthatsays“Iwasrecentlytranscribed.”Andthisisthesortofmarkthatmakesitpossibleforpatternsofgeneregulationtobeepigeneticallyinherited.Asfortherelevanceoftheseyeaststudiestohigherorganisms,hecitedthefamousdictumfromJacquesMonot:“What’struefor<em>E.coli</em>istruefortheelephantonlymoreso.”

&nbsp;

<strong>EpigenomeandInflammation:InductionofahistoneH3Lys27me3demethylasebyNF-kB–alinkbetweeninflammationandPolycomb-mediatedgenesilencing</strong>

Page 36: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

GioacchinoNatoli

EuropeanInstituteofOncology(IEO),CampusIFOM-IEO,Milan

<ahref=""mailto:gioacchino.natoli@ifom-ieo-campus"">gioacchino.natoli@ifom-ieo-campus</a>

Inflammationistheimmunesystem’sfirstresponsetoinfection,irritationordamage,anditsclinicalmanifestationsrangefromthefleetingpainofastubbedtoetochronicinflammatorydiseaseorlethalsepticshock.GioacchinoNatoliisintriguedbyconnectionsbetweeninflammatorystimuliandepigeneticcontrolofchromatinstructure,especiallytheroleoftranscriptionfactorsintheNF-kB/Relfamily.

In2002,heandhiscolleaguesreporteddynamicchangesinH3Lys9methylationinanexperimentalsystemthatusedlipopolysaccharide(LPS)stimulationofculturedhumandentriticcellstosimulatebacterialinfection.Demethylationandremethylationofthissitedeterminedwhatsortsofinflammatorygenesweretranscribedandwhen.

Page 37: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Morerecently,Natoliandhiscolleagueshavebeenexperimentingwithmouseproteinscontainingthe“Jumanji”domain,murineequivalentsofdemethylatingenzymesthatYangShi’slaboratorystudiesatHMS.ThenuclearproteinJmj8isinducedbyLPSstimulationonlywhenNF-kBispresent,Natolisaid,anditremovesthetrimethylgroupfromH3Lys27me3sites.Whenthatgroupisattached,Polycombrepressivecomplexes–whichsilencegenes–areinduced.

TheinvestigatorsnextusedmicroarraystoprobeconnectionsbetweenH3Lys27trimethylationandinflammation.DepletingJmj8didnotchangegloballevelsofH3K27me3,butdidincreasebasallevelsatHoxA11,Natolireported.

AdditionalexperimentsrevealedthatLPSstimulationhadeliciteddramaticallydifferentresponsesindifferentcelltypes.Inmyeloidprecursors,theresearcherswitnessedsustained,high-levelinductionofJmj8andglobalcontrolofHcLys27me3levels.Indifferentiatedmacrophages,Jmj8wastransientlyinducedatalowlevelandtherewasnoglobalimpactonmethylation,Natolisaid.

ThiscouldmeanthatinductionofthisH3Lys27demethylasebyinflammatorystimuligeneratesa“permissivechromatinstate”thatallowsonetypeofcelltoturnintoanother.Therehavebeensignsoftransdifferentiationinchronicallyinflamedcellsoftheeye,kidney,andintestinallining,hesaid.

Iffutureexperimentsconfirmthattransdifferentiationoccursduringinflammationinhismousemodels,duetoepigeneticreprogramming,thiscouldhavemanyimplicationsforhumandisease.

Page 38: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Histonedemethylasescouldturnouttobeadirectmolecularlinkbetweenchronicinflammationandperturbationofdifferentiationprograms(metaplasia)relevantforcancerdevelopment.

&nbsp;

<strong>GrowthPropertiesofNormalandTransformedBreastStemCells</strong>

AngeloCicalese

DepartmentofExperimentalOncology,EuropeanInstituteofOncology,Milan

<ahref=""mailto:[email protected]"">[email protected]</a>

Page 39: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Anti-canceragentswithepigeneticactionarealreadybeingtestedinpatientswithvariouslymphomas,andtheultimategoalofAngeloCicalese’sresearchistoidentifyepigenetictreatmentsforbreastcancer.Arecentseriesofexperimentswithmicesuggeststhatthismaybepossible,Cicalesesaidatthesymposium.

Likeothertissues,tumorsareorganizedhierarchically:theyoriginatefromandaremaintainedbyasmallsubsetofcancerstemcells,orCSCs.CicaleseandhiscolleaguesaskedwhetherepigeneticstrategiescoulddisableCSCsandshrinktumors.

Totestthisidea,theysetupprotocolsforpropagatingbreaststemcellsfromwild-typemousemammarygland(BSCs)andtransformedBSCsfromMMTV-ErbB2transgenicmice.BSCsnotonlysurviveinsuspension,butalsogeneratesphericalcellaggregatescalled“mammospheres.”Mammospheresareclonalinorigin,showthestemcellpropertiesofself-renewalanddifferentiationandarecomposedofBSCsandprogenitors,Cicalesesaid.Duringserialpassages,thenumberofmammospheresformedfromwild-typemousebreasttissuedecreasedatafixedratethrougheachpassage.TheErbB2mammospheres,incontrast,increasedatanexponentialrateanddisplayedanear-immortalphenotype.Mammosphereinitiatingcells,orMICs,accountedforthedisparity;thegrowthrateofprogenitorsdidnotchangeovertime.

TobetterstudythegrowthpropertiesofnormalandtransformedBSCs,theresearchersincorporatedalipophilicdye,PKH26(PKH),intostemcellplasmamembranes.Thisallowedthemtotrackawell-knownpropertyofstemcells:theirabilitytoremaingenerallyquiescentand/orundergofewdivisionswhilegivingrisetoanintermediatepopulationofactivelyproliferatingprogenitors.

Page 40: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

Usingthisprocedurewithnormalbreasttissue,Cicalese’steamfoundthatonlyaminorityofPKH+cellscontinuedformingmammospheresafterbeingdissociatedandreplatedseveraltimes.Afewofthelabeledcellswereabletogeneratemammarytissuewhentransplantedintoanotheranimal’sfatpad,showingthattheyaretrulystemcells.

BSCsfromMMTV-Erb2micewereanentirelydifferentstory.BothPKH+andPKH-populationsformedmammospheres<em>invitro</em>andinitiatedtumorsaftertransplantation,Cicalesereported.TheseErbB2mammospheresandbreastcancertissuescontainedmoreBSCsthannormalmammospheresandtissue.TheresearchersattributethistoincreasedsymmetricdivisionsofcancerBSCs,atypeofgrowthpatternalsoseeninBSCsfrommicemissingthep53tumorsuppressorgene.

Knowingthatmutatedorfunctionallysuppressedp53isacommonfeatureofErbB2tumors,theinvestigatorsspeculatedthatp53malfunctionmightaccountforincreasedsymmetricdivisionsoftransformedBSCsintheirexperiments.TheyusedNutlin3,anMDM2antagonist,toblockp53degradationandrestoreitsfunction.Theresultwasacompletereversaloftheirearlierresults,hintingthatepigenetictreatmentsforbreastcancermaybepossibleinthefuture.

&nbsp;

<strong>ExitfromMitosisinBuddingYeastSaccharomycescerevisiae</strong>

Page 41: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

RosellaVisintin

DepartmentofExperimentalOncology,EuropeanInstituteofOncology,Milan

<ahref=""mailto:[email protected]"">[email protected]</a>

Anyonewhohaseverbeateneggwhitesknowsthattimingiseverything:whiskafewsecondstoolongandyou’llhaveamess,notameringue.Mitosisisnodifferent:cellsmustexitatpreciselytherightmomentorruntheriskofaccumulatingchromosomesegregationerrorsandgeneticinstabilityassociatedwithcancer.

UnderstandinghowcellsexitmitosisisthefocusofRosellaVisintin’slaboratory,whichshefoundedin2005withsupportfromaCareerDevelopmentAward.Sheusesthebuddingyeast<em>Saccharomycescerevisiae</em>asamodelforstudyingcellcycleprogression,whichinalleukaryotesistriggeredandcoordinatedbyasetofproteinsincludingcyclins,cyclin-dependentkinases(CDKs)andtheirinhibitors.

Page 42: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

PhosphorylationofproteinsbymitoticCDKsdrivesmitosis,andafterchromosomesareaccuratelysegregatedthesesameCDKsmustbeinactivatedsocellscanleavemitosisandentertheG1phase.Inyeast,thephosphataseCdc14emergesfromthenucleolus,whereithasbeenboundtobytheinhibitorysubunitCfi1,andspreadsintothenucleusandcytoplasm.Itzeroesinonitstargets,bringsmitosistoasuddenhalt,andretreatsswiftlytothenucleolus.

Visintinandhercolleagueshavebeenexploringhowtworegulatorynetworks,calledFEAR(CdcFourteenEarlyAnaphaseRelease)andMEN(MitoticExitNetwork)controltheassociationofCdc14withCfi1andpromoteCdc14’sreleasefromthenucleolus.Inhersymposiumpresentation,Visintinfocusedontheflipsideofthecoin:mechanismsthatrapidlyinactivateCdc14aftermitoticexit.

TheproteinkinaseCdc5,acomponentofboththeFEARandMENnetworks,helpsliberateCdc14fromCfi1soitcanleavethenucleolus.WorkintheVisintinlabindicatesthatinactivationofCdc5isnecessary–butprobablynotsufficient–toreturnCdc14toitsstorageplace.

“Cdc14plantstheseedsforitsowninactivation”viatheFEARandMENnetworks,Visintinsaid,butexactlyhowthisworksremainstobeseen.Answersfromyeastwillberelevantforhumans,becausethesameplayers–Cdc14,FEARandMEN–helpregulatecelldivisionandmaintaingenomicintegrityinhumans.

<palign=""left""><strong><brclear=""all""/></strong></p>

Page 43: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<strong>Dances-with-Retroviruses:The40MillionYearSagaofthe<em>TRIM5</em>Locus</strong>

WelkinJohnson

NewEnglandPrimateResearchCenter,DepartmentofMicrobiologyandMolecularGenetics,HarvardMedicalSchool

<ahref=""mailto:[email protected]"">[email protected]</a>

Despiteitsglobalprominenceformorethan20years,inthelongruntheHIV/AIDSsagamaybeasfleetingasaCNNheadlineaboutthelatestcarbombinBaghdad.Thehumangenomeisstuddedwiththefossilfootprintsofretrovirusencountersstretchingbacktensofmillionsofyears,WelkinJohnsonsaid,longbeforeAIDS.Thesebattlesbetweenhostandpathogenarememorializedinthegermlineandpassedfromonegenerationtothenextasfeaturesofinnateimmunity.

OneofthesefootprintsistheTRIM5locus.SincetheearlyyearsofHIV/AIDS,researchershaverealizedthatageneticbarrierkeptHIV-1fromthrivinginoldworldmonkeys–makingtheircellsunsuitableasmodelsforHIVreplicationandAIDS.Incontrast,humancellsarecatastrophically

Page 44: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

susceptibletoHIV-1infection,butabletorepelsomeotherretrovirusinfections.Alandmark2004articleidentifiedtherhesusmonkeyTRIM5gene,andspecificallytheTRIM5 alphasplice-isoform,asadeal-breakerthatblocksHIVreplicationinthecytoplasm,preventingtheretrovirusfrompenetratingthehostnucleus.

TRIM5aisabroad-spectrumantiviralwhosespecificcapacitiesareshapedbyeachprimate’shistory.WhenJohnson’steamcompared<em>TRIM5</em>fromoldandnewworldprimatestheyfoundahighdegreeofinterspeciesdivergenceandevidence,fromdN/dScomparisons,thatstrongpositiveselectionwasimportant.Theseobservationsmotivatedthemtoexploreintraspeciesdiversity,orpolymorphism,intheprimate<em>TRIM5</em>locus.Theybeganbysurveyingindividualsrepresentingthreespecies,anAfricanmonkey(sootymangabeys)andtwoAsianmonkeys(rhesusmacaquesandpig-tailmacaques).Theyweresurprisedtofindahighdegreeofpolymorphism,includingmultipleinstancesofsharedpolymorphism,Johnsonreported.Bothnon-synonymousandsynonymousSNPswereclusteredintworegionsofthegene,correspondingtotwodistinctdomainsintheTRIM5a protein.

Thehuman<em>TRIM5</em>locus,incontrast,wasmoremonomorphicoverallanddisplayednovariationsinsomeregionsthatwerehighlypolymorphicinotherprimates.Forexample,contemporaryhumanshaveanargeninealleleatpositionaa334,whereprimatesarepolymorphic.ThehumanalleleisassociatedwithsusceptibilityofcellstoHIVreplication,whileprimateswithaprolineinthispositionresistHIV.FormillionsofyearstheTRIM5a locushasbeenthesceneofastruggle,Johnsonspeculated,betweenpositiveselectionpressureandotherforcesdeterminedtomaintainmultipleallelesatintermediatefrequenciesformillionsofyears,evenasspeciesdiverged.

Itispossiblethatonlyhumanswiththeargenineallelesurvivedaprehistoricretroviralepidemic,Johnsonsaid,onlytohavetheselectionofthatTRIM5sequenceopenthedoortoAIDSmillionsofyearslater.Ifthatistrue,theTRIM5alphastoryisbiology’sversionofaGreektragedy,wherethehero’sstrengthultimatelyprovestobehisundoing.

Page 45: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

<strong></strong>

<strong>ANon-codingRNAPotentiallyRegulating4q35GenesExpressioninFSHD</strong>

<palign=""left"">DavideGabellini</p>

<palign=""left"">DulbeccoTelethonInstituteatStemCellResearchInstitute,DIBIT-HSR,Milan</p>

<ahref=""mailto:[email protected]"">[email protected]</a>

Thethirdmostcommonformofmusculardystrophyisnamedforthebizarrewaysymptomsemerge,withpatientsgraduallylosingtheuseofmusclesintheface,shouldergirdleandupperarms.Calledfacioscapulohumeralmusculardystrophy(FSHD),thisautosomaldominantdiseasestrikesapproximatelyonein20,000people.Thecourseoftheillnessvaries,butthehallmarkmusclegroupswastegradually,othermusclesweakenandmanypatientslosemobilitywithage.TherearecurrentlynotreatmentsforFSHD.

Page 46: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

ThegoalofDavideGabellini’slaboratoryistocharacterizethemolecularpathogenesisofFSHDanddevelopnewtherapies.In2002,hewaspartofateamthattracedthediseasetoadeletioninthe4q35regionofchromosomefour.Thisregioncontainsthemolecularequivalentofastudy-hallmonitor:itkeepsbadboysquietandintheirseats,butremoveitandtheygowild.

Thelostsegmentof4q35isnotpartofaprotein-codinggene,butoccursinanon-codingrepetitiveelementcalledD4Z4.Healthypeoplehave11to150copiesofthisrepeat;FSHDpatientshaveoneto11copies.D4Z4isheavilymethylated,hasheterochromaticfeatures,andcontainsatranscriptionalsilencerwhosedeletionpermitsinappropriateover-expressionofnearbyupstreamgenes.

GabelliniandhiscolleagueslateridentifiedthreegenesthatbecameboisterousincellswiththeFSHDdeletion.Oneofthem,dubbedFRG1(forFSHDregiongene1)causedFSHDsymptomswhenover-expressedintransgenicmice,theyreportedin<em>Nature</em>inDecember2006.Theresearchersalsodiscoveredaberrantalternativesplicinginspecificpre-mRNAsinthemusclesofFRG1transgenicmiceandFSHDpatients.

Additionalstudiesinpatientsamplesindicatethatpeoplewithearly-onset,severeFSHDhaveveryfewcopiesofD4Z4.Oddlyenough,peopledevoidofD4Z4arehealthyandsymptomfree.

AlthoughdeletingD4Z4issufficienttocreateamousemodelforFSHD,Gabellenisaysthelossofregulationofneighboringgenes,suchasFRG1,probablyinvolvesotherfactorsaswell.AsforFRG1,itisprobablyoneofagroupofgenesthataffectRNAsplicing,whichinturndetermineswhat

Page 47: G EPIGENETIC REGULATORY MECHANISMS IN HUMAN DISEASE · “Genetic and Epigenetic Regulatory Mechanisms in Human Disease”. ... On the day before the Armenise-Harvard Symposium began,

proteinsaremadebycells.Whilehisteamcontinuestoinvestigatethemolecularpathogenesisofthisfascinatingdisease,theyalsohopetouseFRG1transgenicmicetoscreenforpossibletherapies.